FDA approves Regeneron antibody drug as first Ebola virus treatment

The Food and Drug Administration on Wednesday approved the first treatment for the Ebola virus, clearing an antibody drug cocktail that was shown in a landmark 2019 study to reduce the risk of dying from the lethal and feared infectious disease.